| 0 |
EOSINOPHIL MORPHOLOGY ABNORMAL |
1 |
0.0833 |
| 1 |
SPUR CELL ANAEMIA |
2 |
0.0299 |
| 2 |
NEUTROPHIL MORPHOLOGY ABNORMAL |
1 |
0.0175 |
| 3 |
HYPOZINCAEMIA |
1 |
0.0169 |
| 4 |
SOMATOSENSORY EVOKED POTENTIALS ABNORMAL |
1 |
0.0167 |
| 5 |
ASTHENOSPERMIA |
1 |
0.0154 |
| 6 |
MICROVILLOUS INCLUSION DISEASE |
1 |
0.0133 |
| 7 |
NEUROMYOPATHY |
10 |
0.0094 |
| 8 |
NEUROMUSCULAR TOXICITY |
2 |
0.0057 |
| 9 |
HYPOCHOLESTEROLAEMIA |
1 |
0.0028 |
| 10 |
INFERTILITY |
3 |
0.0020 |
| 11 |
OEDEMATOUS PANCREATITIS |
1 |
0.0018 |
| 12 |
ACUTE LUNG INJURY |
2 |
0.0017 |
| 13 |
MYOPATHY TOXIC |
1 |
0.0016 |
| 14 |
ABDOMINAL COMPARTMENT SYNDROME |
1 |
0.0016 |
| 15 |
SENILE DEMENTIA |
1 |
0.0015 |
| 16 |
HEPATITIS TOXIC |
3 |
0.0012 |
| 17 |
MYOPATHY |
9 |
0.0010 |
| 18 |
MUCOSAL HAEMORRHAGE |
1 |
0.0009 |
| 19 |
SINUS ARRHYTHMIA |
1 |
0.0008 |
| 20 |
ACCIDENTAL POISONING |
1 |
0.0007 |
| 21 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
18 |
0.0006 |
| 22 |
NASAL ULCER |
1 |
0.0006 |
| 23 |
SPLEEN DISORDER |
1 |
0.0006 |
| 24 |
HYPERAMMONAEMIC ENCEPHALOPATHY |
1 |
0.0006 |
| 25 |
DISSEMINATED INTRAVASCULAR COAGULATION |
8 |
0.0006 |
| 26 |
GASTROINTESTINAL OEDEMA |
1 |
0.0006 |
| 27 |
BICYTOPENIA |
1 |
0.0005 |
| 28 |
SMALL INTESTINAL HAEMORRHAGE |
1 |
0.0005 |
| 29 |
HYPERPHOSPHATAEMIA |
1 |
0.0005 |
| 30 |
NEUROLOGICAL DECOMPENSATION |
1 |
0.0004 |
| 31 |
ABDOMINAL TENDERNESS |
2 |
0.0004 |
| 32 |
LEUKOCYTOSIS |
7 |
0.0004 |
| 33 |
AREFLEXIA |
1 |
0.0004 |
| 34 |
JOINT LOCK |
1 |
0.0004 |
| 35 |
HYPERTONIC BLADDER |
1 |
0.0003 |
| 36 |
HYPERTRIGLYCERIDAEMIA |
2 |
0.0003 |
| 37 |
HISTIOCYTOSIS HAEMATOPHAGIC |
1 |
0.0003 |
| 38 |
NORMOCHROMIC NORMOCYTIC ANAEMIA |
1 |
0.0003 |
| 39 |
ENTERITIS |
2 |
0.0003 |
| 40 |
LYME DISEASE |
1 |
0.0003 |
| 41 |
APLASIA PURE RED CELL |
1 |
0.0003 |
| 42 |
LEFT VENTRICULAR FAILURE |
1 |
0.0003 |
| 43 |
FUNCTIONAL GASTROINTESTINAL DISORDER |
1 |
0.0003 |
| 44 |
THROMBOCYTOSIS |
1 |
0.0003 |
| 45 |
RHABDOMYOLYSIS |
11 |
0.0003 |
| 46 |
HAEMODYNAMIC INSTABILITY |
2 |
0.0003 |
| 47 |
CONJUNCTIVAL HAEMORRHAGE |
1 |
0.0003 |
| 48 |
SHOCK |
6 |
0.0003 |
| 49 |
CARDIOPULMONARY FAILURE |
1 |
0.0003 |
| 50 |
INTENTIONAL OVERDOSE |
16 |
0.0002 |
| 51 |
INTERNATIONAL NORMALISED RATIO DECREASED |
1 |
0.0002 |
| 52 |
BONE MARROW FAILURE |
5 |
0.0002 |
| 53 |
TOXICITY TO VARIOUS AGENTS |
39 |
0.0002 |
| 54 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
4 |
0.0002 |
| 55 |
DRUG LEVEL ABOVE THERAPEUTIC |
1 |
0.0002 |
| 56 |
CARDIAC TAMPONADE |
1 |
0.0002 |
| 57 |
CARDIOGENIC SHOCK |
3 |
0.0002 |
| 58 |
HYPOVOLAEMIC SHOCK |
1 |
0.0002 |
| 59 |
SINUS BRADYCARDIA |
2 |
0.0002 |
| 60 |
TOXIC ENCEPHALOPATHY |
1 |
0.0002 |
| 61 |
ENDOCARDITIS |
1 |
0.0002 |
| 62 |
PERIORBITAL OEDEMA |
1 |
0.0002 |
| 63 |
HEREDITARY ANGIOEDEMA |
2 |
0.0002 |
| 64 |
HEPATOTOXICITY |
4 |
0.0002 |
| 65 |
PANCYTOPENIA |
10 |
0.0002 |
| 66 |
PULMONARY ALVEOLAR HAEMORRHAGE |
1 |
0.0002 |
| 67 |
CIRCULATORY COLLAPSE |
3 |
0.0002 |
| 68 |
ENTEROCOLITIS |
1 |
0.0002 |
| 69 |
BLOOD URIC ACID INCREASED |
1 |
0.0002 |
| 70 |
HYPOVOLAEMIA |
1 |
0.0002 |
| 71 |
GANGRENE |
1 |
0.0002 |
| 72 |
OLIGURIA |
1 |
0.0002 |
| 73 |
ILEUS |
2 |
0.0002 |
| 74 |
ATRIOVENTRICULAR BLOCK COMPLETE |
1 |
0.0001 |
| 75 |
LEFT VENTRICULAR DYSFUNCTION |
1 |
0.0001 |
| 76 |
ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD |
1 |
0.0001 |
| 77 |
ACUTE HEPATIC FAILURE |
2 |
0.0001 |
| 78 |
ECCHYMOSIS |
1 |
0.0001 |
| 79 |
RESPIRATION ABNORMAL |
1 |
0.0001 |
| 80 |
LIVER FUNCTION TEST INCREASED |
3 |
0.0001 |
| 81 |
HYPOPHOSPHATAEMIA |
1 |
0.0001 |
| 82 |
HEPATIC FAILURE |
4 |
0.0001 |
| 83 |
ATRIOVENTRICULAR BLOCK |
1 |
0.0001 |
| 84 |
FURUNCLE |
1 |
0.0001 |
| 85 |
METABOLIC ACIDOSIS |
4 |
0.0001 |
| 86 |
STENT PLACEMENT |
1 |
0.0001 |
| 87 |
SHOCK HAEMORRHAGIC |
1 |
0.0001 |
| 88 |
PURPURA |
1 |
0.0001 |
| 89 |
GASTRIC ULCER |
2 |
0.0001 |
| 90 |
ACUTE RESPIRATORY FAILURE |
2 |
0.0001 |
| 91 |
EAR PAIN |
2 |
0.0001 |
| 92 |
TENDERNESS |
1 |
0.0001 |
| 93 |
OESOPHAGITIS |
1 |
0.0001 |
| 94 |
TRANSAMINASES INCREASED |
2 |
0.0001 |
| 95 |
MICTURITION URGENCY |
1 |
0.0001 |
| 96 |
MYOCARDITIS |
1 |
0.0001 |
| 97 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 98 |
DRUG INTOLERANCE |
8 |
0.0001 |
| 99 |
ADRENAL INSUFFICIENCY |
1 |
0.0001 |
| 100 |
POISONING |
1 |
0.0001 |
| 101 |
BRAIN OEDEMA |
1 |
0.0001 |
| 102 |
MUSCLE ATROPHY |
1 |
0.0001 |
| 103 |
DRUG INTERACTION |
12 |
0.0001 |
| 104 |
JAUNDICE |
2 |
0.0001 |
| 105 |
TACHYPNOEA |
1 |
0.0001 |
| 106 |
LYMPHOPENIA |
1 |
0.0001 |
| 107 |
HEPATOCELLULAR INJURY |
1 |
0.0001 |
| 108 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
2 |
0.0001 |
| 109 |
SEPTIC SHOCK |
3 |
0.0001 |
| 110 |
LIVER FUNCTION TEST ABNORMAL |
2 |
0.0001 |
| 111 |
HAEMORRHAGE INTRACRANIAL |
1 |
0.0001 |
| 112 |
CYANOSIS |
1 |
0.0001 |
| 113 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1 |
0.0001 |
| 114 |
MUSCULAR WEAKNESS |
7 |
0.0001 |
| 115 |
VENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 116 |
HEMIPARESIS |
1 |
0.0001 |
| 117 |
HAEMATURIA |
2 |
0.0001 |
| 118 |
LOCAL SWELLING |
1 |
0.0001 |
| 119 |
HYPOXIA |
2 |
0.0001 |
| 120 |
THIRST |
1 |
0.0001 |
| 121 |
END STAGE RENAL DISEASE |
1 |
0.0001 |
| 122 |
ACCIDENTAL OVERDOSE |
2 |
0.0001 |
| 123 |
THROMBOCYTOPENIA |
6 |
0.0001 |
| 124 |
COLITIS |
2 |
0.0001 |
| 125 |
PROTEINURIA |
1 |
0.0001 |
| 126 |
PLASMA CELL MYELOMA |
2 |
0.0001 |
| 127 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 128 |
CARDIAC ARREST |
4 |
0.0000 |
| 129 |
COMPLETED SUICIDE |
4 |
0.0000 |
| 130 |
ALTERED STATE OF CONSCIOUSNESS |
1 |
0.0000 |
| 131 |
FAECES DISCOLOURED |
1 |
0.0000 |
| 132 |
ACUTE KIDNEY INJURY |
7 |
0.0000 |
| 133 |
FEBRILE NEUTROPENIA |
3 |
0.0000 |
| 134 |
RASH MACULO-PAPULAR |
1 |
0.0000 |
| 135 |
DIARRHOEA |
29 |
0.0000 |
| 136 |
ORAL PAIN |
1 |
0.0000 |
| 137 |
PANCREATITIS ACUTE |
1 |
0.0000 |
| 138 |
NEPHROLITHIASIS |
2 |
0.0000 |
| 139 |
MYALGIA |
7 |
0.0000 |
| 140 |
AGITATION |
3 |
0.0000 |
| 141 |
ALOPECIA |
8 |
0.0000 |
| 142 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 143 |
ABASIA |
1 |
0.0000 |
| 144 |
HAEMATEMESIS |
1 |
0.0000 |
| 145 |
ACCIDENTAL EXPOSURE TO PRODUCT |
4 |
0.0000 |
| 146 |
DEAFNESS |
1 |
0.0000 |
| 147 |
GASTRITIS |
1 |
0.0000 |
| 148 |
BRADYCARDIA |
2 |
0.0000 |
| 149 |
PALLOR |
1 |
0.0000 |
| 150 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 151 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 152 |
HAEMOPTYSIS |
1 |
0.0000 |
| 153 |
DEMENTIA |
1 |
0.0000 |
| 154 |
RENAL IMPAIRMENT |
3 |
0.0000 |
| 155 |
ASCITES |
1 |
0.0000 |
| 156 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 157 |
RENAL INJURY |
1 |
0.0000 |
| 158 |
PRODUCT USE IN UNAPPROVED INDICATION |
8 |
0.0000 |
| 159 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 160 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 161 |
HYPOTENSION |
6 |
0.0000 |
| 162 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
| 163 |
HEPATIC ENZYME INCREASED |
2 |
0.0000 |
| 164 |
DELIRIUM |
1 |
0.0000 |
| 165 |
HAEMORRHAGE |
3 |
0.0000 |
| 166 |
OVERDOSE |
6 |
0.0000 |
| 167 |
VOMITING |
13 |
0.0000 |
| 168 |
RESPIRATORY FAILURE |
2 |
0.0000 |
| 169 |
RESTLESSNESS |
1 |
0.0000 |
| 170 |
HEPATIC FUNCTION ABNORMAL |
1 |
0.0000 |
| 171 |
PRODUCT USE ISSUE |
5 |
0.0000 |
| 172 |
CHRONIC KIDNEY DISEASE |
2 |
0.0000 |
| 173 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 174 |
ABDOMINAL PAIN |
6 |
0.0000 |
| 175 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 176 |
POLLAKIURIA |
1 |
0.0000 |
| 177 |
ANGIOEDEMA |
1 |
0.0000 |
| 178 |
RENAL FAILURE |
3 |
0.0000 |
| 179 |
DEHYDRATION |
3 |
0.0000 |
| 180 |
HYPOKALAEMIA |
1 |
0.0000 |
| 181 |
ARRHYTHMIA |
1 |
0.0000 |
| 182 |
COMA |
1 |
0.0000 |
| 183 |
LEUKOPENIA |
1 |
0.0000 |
| 184 |
HAEMOGLOBIN DECREASED |
2 |
0.0000 |
| 185 |
ILLNESS |
2 |
0.0000 |
| 186 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 187 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 188 |
ARTHROPATHY |
1 |
0.0000 |
| 189 |
SEPSIS |
2 |
0.0000 |
| 190 |
NECK PAIN |
1 |
0.0000 |
| 191 |
HYPONATRAEMIA |
1 |
0.0000 |
| 192 |
FLATULENCE |
1 |
0.0000 |
| 193 |
LETHARGY |
1 |
0.0000 |
| 194 |
PYREXIA |
6 |
0.0000 |
| 195 |
NASAL CONGESTION |
1 |
0.0000 |
| 196 |
VERTIGO |
1 |
0.0000 |
| 197 |
DISCOMFORT |
1 |
0.0000 |
| 198 |
ANAEMIA |
3 |
0.0000 |
| 199 |
LOSS OF CONSCIOUSNESS |
2 |
0.0000 |
| 200 |
HALLUCINATION |
1 |
0.0000 |
| 201 |
PARAESTHESIA |
2 |
0.0000 |
| 202 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 203 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 204 |
COVID-19 |
2 |
0.0000 |
| 205 |
TACHYCARDIA |
1 |
0.0000 |
| 206 |
NASOPHARYNGITIS |
2 |
0.0000 |
| 207 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 208 |
SWELLING |
1 |
0.0000 |
| 209 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 210 |
GAIT DISTURBANCE |
2 |
0.0000 |
| 211 |
CONTUSION |
1 |
0.0000 |
| 212 |
PAIN IN EXTREMITY |
3 |
0.0000 |
| 213 |
DYSPEPSIA |
1 |
0.0000 |
| 214 |
NAUSEA |
8 |
0.0000 |
| 215 |
PLATELET COUNT DECREASED |
1 |
0.0000 |
| 216 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 217 |
INCORRECT DOSE ADMINISTERED |
2 |
0.0000 |
| 218 |
SEIZURE |
1 |
0.0000 |
| 219 |
BACK PAIN |
2 |
0.0000 |
| 220 |
PALPITATIONS |
1 |
0.0000 |
| 221 |
JOINT SWELLING |
1 |
0.0000 |
| 222 |
HYPERHIDROSIS |
1 |
0.0000 |
| 223 |
NEUTROPENIA |
1 |
0.0000 |
| 224 |
WEIGHT DECREASED |
2 |
0.0000 |
| 225 |
COUGH |
2 |
0.0000 |
| 226 |
INFECTION |
1 |
0.0000 |
| 227 |
HYPOAESTHESIA |
1 |
0.0000 |
| 228 |
CONDITION AGGRAVATED |
2 |
0.0000 |
| 229 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 230 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 231 |
DIZZINESS |
3 |
0.0000 |
| 232 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 233 |
DEATH |
5 |
0.0000 |
| 234 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 235 |
CHEST PAIN |
1 |
0.0000 |
| 236 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 237 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 238 |
WEIGHT INCREASED |
1 |
0.0000 |
| 239 |
DEPRESSION |
1 |
0.0000 |
| 240 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 241 |
PAIN |
2 |
0.0000 |
| 242 |
PNEUMONIA |
1 |
0.0000 |
| 243 |
ASTHENIA |
1 |
0.0000 |
| 244 |
ARTHRALGIA |
1 |
0.0000 |
| 245 |
RASH |
1 |
0.0000 |
| 246 |
DYSPNOEA |
1 |
0.0000 |
| 247 |
HEADACHE |
1 |
0.0000 |